| Drug Name | Betaferon (interferon beta-1a) |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Neurology
|
| Risk |
Communication on the association of Interferon Beta with the risk of thrombotic microangiopathy and nephrotic syndrome |
| Dear Healthcare provider letter DHPC |
|